Talphera Inc. entered into securities purchase agreements with CorMedix Inc. and several institutional investors, resulting in the issuance and sale of 25,036,360 shares of common stock at a purchase price of $0.55 per share. Additionally, pre-funded warrants to purchase up to 5,845,455 shares were sold, with an exercise price of $0.001 per share. The first closing of the private placement on September 10, 2025, generated approximately $17 million in gross proceeds. An additional purchase of approximately $12 million in shares or warrants by the Purchasers, excluding CorMedix, is contingent upon specific conditions being met.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Talphera Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-028787), on September 10, 2025, and is solely responsible for the information contained therein.